Search results
Democratic Lawmakers Start to Publicly Back Away From Biden
The Fiscal Times via Yahoo Singapore Finance· 3 hours agoDemocrats have been freaking out for days about President Joe Biden’s terrible debate performance...
As convention inches closer, Trump holds rally in Miami amid growing VP speculation
CNN via Yahoo News Singapore· 4 hours agoThroughout the week of the presidential debate, some members of former President Donald Trump’s team...
Biden support nosedives in swing states after disastrous debate against Trump
The Independent via Yahoo News Singapore· 4 hours agoThat’s according to a confidential polling memo obtained by PuckNews. It reveals that states where...
What to Watch For as Biden Doubles Down Amid Party Panic
Time via Yahoo News Singapore· 4 hours agoWhat will the next batch of polls say? All of Washington is waiting for a better sense of how the...
White House’s Day from Hell as Dems Open Fire on Biden
The Daily Beast via Yahoo News Singapore· 4 hours agoWithin...
Trump hush money sentencing delayed after Supreme Court gives ex-president substantial immunity:...
The Independent via Yahoo News Singapore· 5 hours agoHe writes that Biden's debate performance “didn’t rattle me as it has others, because the outcome of...
New Yahoo News/YouGov poll: 60% of Americans say Biden is not fit for another term as president...
Yahoo News· 5 hours agoBefore the debate, slightly more Americans said Trump’s criminal charges were a bigger problem than...
Latinos represent nearly a third of new HIV diagnoses in the US, CDC data shows
CNN via Yahoo News Singapore· 6 hours agoLatinos or Hispanic people represent less than 20% of the US population but they made up nearly a...
Biden to meet with Democratic governors amid angst over debate
NY Daily News via Yahoo News Singapore· 6 hours agoPresident Joe Biden reportedly plans to meet with Democratic governors Wednesday amid ongoing angst...
FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease
CNN via Yahoo News Singapore· 7 hours agoThe US Food and Drug Administration on Tuesday approved donanemab, a monoclonal antibody designed to slow the progression of early symptomatic Alzheimer’s disease.